Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-24 @ 3:43 PM
NCT ID:
NCT05678192
Eligibility Criteria:
Inclusion Criteria:
* age from 45 to 59;
* phase of reproductive aging - perimenopause, postmenopause or surgical menopause (ovariectomy);
* indications for prescribing MHT
Exclusion Criteria:
1. Absolute contraindications to MHT:
* Bleeding from the genital tract of unknown origin
* Breast and endometrial cancer
* Acute hepatitis
* Acute deep vein thrombosis
* Acute thromboembolism
* Cutaneous porphyria
2. Obesity;
3. HIV infection and other congenital and acquired immunodeficiencies;
4. Systemic connective tissue diseases;
5. Oncological diseases in history;
6. History of chemotherapy and/or radiation therapy;
7. Autoimmune diseases;
8. Acute diseases and exacerbation of chronic diseases during the last 3 months;
9. Reception of immunomodulatory drugs during the last 3 months.
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
45 Years
Maximum Age:
59 Years
Study:
NCT05678192
Study Brief:
Protocol Section:
NCT05678192